Evidence-Based Practice Podcast and Literature series which features succinct commentaries about practice-changing evidence through a series of podcasts, articles, online panel discussions, and polls. These activities are produced in conjunction with iForumRx and are part of the APhA professional development program for BCACP recertification approved by BPS.
Additional Modules can be found here: Evidence-Based Practice Podcast and Literature Series.
At the completion of this activity, the participant will be able to:
"Extracting" Data on CBD: Potential Effects on Opioid Use and Quality of Life
- Identify various preparations of cannabinoids (CBD) used for chronic pain and associated comorbidities.
- Appraise a recently published study evaluating the effect of cannabidiol (CBD)-rich hemp extract on opioid use and quality of life indices
- Apply available evidence in the management of chronic pain and its associated comorbidities, given a patient case.
Is This the Comeback Canagliflozin Has Been Waiting For? New Data on the Risk of Amputation
- Given a case, evaluate whether a patient is meeting appropriate treatment goals for diabetes.
- Given a case, develop a patient-centered regimen to control blood glucose and minimize risk of cardiovascular and renal outcomes.
- Evaluate evidence-based literature to determine if and when canagliflozin should be used to treat type 2 diabetes.
Is Less More? Deprescribing of Antihypertensive Medications in Older Adult
- Identify patients who would be candidates for deprescribing of antihypertensives based on the OPTIMISE study.
- Choose an antihypertensive medicine to deprescribe in a patient who meets eligibility criteria.
- Communicate the overall impact of deprescribing antihypertensives in an elderly population.
Shared Decision-Making Tools - When is it worth it?
- Explain the potential benefits and limitations to using a shared decision making (SDM) approach in patient encounters.
- Evaluate the use of a SDM tool on patient and provider outcomes when selecting anticoagulants to prevent stroke in people with atrial fibrillation.
- Apply principles of SDM to conditions commonly managed by pharmacists.
Activity type: Application-based
Target Audience: Pharmacists
Learning level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2 contact hours of CPE credit (0.2 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-183-H04-P.
To obtain credit for completing Evidence-Based Practice Module 11, complete the learning activity in full, the assessment with a grade of 70% or better, and evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password and CPE Monitor account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript
To obtain recertification credit for completing Evidence-Based Practice Module 11, complete the activity which includes receiving 70% or better on assessment, answer evaluation questions, and then CLAIM the Board Certification credit. Participants need to have a valid MyBPS account to claim recertification credit. After recertification credit has been claimed, a participant can access transcript by signing into your MyBPS account.
Per Board of Pharmacy Specialties policy you will only have one opportunity to successfully complete this ACPE / BCSCP recertification assessment. You will only have one opportunity to complete this activity once during this release year.ACPE Initial release date: June 4, 2021
ACPE Expiration date: June 4, 2024 No ACPE credit can be claimed after this date
BCSCP release date: June 4, 2021
BCSCP Expiration date: June 4, 2022 No recertification credit can be claimed after this date
Evidence-Based Practice Module 11 is an online educational activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association
Disclosures for authors found on iForumRx.org. APhA’s editorial staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
APhA Member: $40
APhA Non-member: $70
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-21-183-H04-P||0.2 CEUs||June 01, 2021 - June 01, 2024|
|BCACP_21183H04P||2 Hours||June 01, 2021 - June 01, 2024|